a drug used to increase the number of blood cells, especially platelets, in some cancer patients receiving chemotherapy. rhil-11 is a form of interleukin-11 (a cytokine normally made by support cells in the bone marrow) that is made in the laboratory. it is a type of biological response modifier. also called neumega, oprelvekin, and recombinant human interleukin-11.